ResearcherTongji HospitalActive in the last 2 years

Hui Hu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9208-1041; OpenAlex author ID A5100422517. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

Single-Cell RNA Sequencing Analysis Reveals Metabolic Changes in Epithelial Glycosphingolipids and Establishes a Prognostic Risk Model for Pancreatic Cancer. Co-author DOI 10.3390/diagnostics14111094 ↗
MicroRNA-301a promotes pancreatic cancer invasion and metastasis through the JAK/STAT3 signaling pathway by targeting SOCS5. Co-author DOI 10.1093/carcin/bgz121 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Qinwen Ba · 1 shared paper, 2024 · strength 0.31
- Paper Single-Cell RNA Sequencing Analysis Reveals Metabolic Changes in Epithelial Glycosphingolipids and Establishes a Progno… DOI 10.3390/diagnostics14111094 ↗
Xiong Wang · 1 shared paper, 2024 · strength 0.31
- Paper Single-Cell RNA Sequencing Analysis Reveals Metabolic Changes in Epithelial Glycosphingolipids and Establishes a Progno… DOI 10.3390/diagnostics14111094 ↗
Yanjun Lu · 1 shared paper, 2024 · strength 0.31
- Paper Single-Cell RNA Sequencing Analysis Reveals Metabolic Changes in Epithelial Glycosphingolipids and Establishes a Progno… DOI 10.3390/diagnostics14111094 ↗
Zhongxin Lu · 1 shared paper, 2020 · strength 0.11
- Paper MicroRNA-301a promotes pancreatic cancer invasion and metastasis through the JAK/STAT3 signaling pathway by targeting S… DOI 10.1093/carcin/bgz121 ↗
Tianzhu Zhang · 1 shared paper, 2020 · strength 0.11
- Paper MicroRNA-301a promotes pancreatic cancer invasion and metastasis through the JAK/STAT3 signaling pathway by targeting S… DOI 10.1093/carcin/bgz121 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.